Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 58.
[20-40] [0 - 20][0 - 50][40-57][40-60]

Ident.	Authors (with country if any)	Title
000788 (2008)	Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette Akwa	Disease-modifying drugs and Parkinson's disease.
000922 (2009)	Nathalie Chastan [France] ; Manh Cuong Do ; Fabrice Bonneville ; Frédéric Torny ; Frédéric Bloch ; G W Max Westby ; Didier Dormont ; Yves Agid [France] ; Marie-Laure Welter	Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
000964 (2009)	A. Degardin [France] ; E. Houdayer ; J-L Bourriez ; A. Destée ; L. Defebvre ; P. Derambure ; D. Devos	Deficient "sensory" beta synchronization in Parkinson's disease.
000A39 (2009)	Karim Farid [France] ; Igor Sibon ; Dominique Guehl ; Emmanuel Cuny ; Pierre Burbaud ; Michèle Allard	Brain dopaminergic modulation associated with executive function in Parkinson's disease.
000A61 (2010)	Stéphanie Cantiniaux [France] ; Marianne Vaugoyeau ; Danièle Robert ; Christine Horrelou-Pitek ; Julien Mancini ; Tatiana Witjas ; Jean-Philippe Azulay	Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
000B24 (2010)	David Devos [France] ; L. Defebvre ; R. Bordet	Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
000B85 (2010)	Santiago Perez Lloret [France] ; Olivier Rascol	Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
000C31 (2011)	V. Marchand-Pauvert [France] ; A. Gerdelat-Mas ; F. Ory-Magne ; F. Calvas ; D. Mazevet ; S. Meunier ; C. Brefel-Courbon ; M. Vidailhet ; M. Simonetta-Moreau	Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
000C37 (2011)	Estelle Dellapina [France] ; Angélique Gerdelat-Mas ; Fabienne Ory-Magne ; Laure Pourcel ; Monique Galitzky ; Fabienne Calvas ; Marion Simonetta-Moreau ; Claire Thalamas ; Pierre Payoux ; Christine Brefel-Courbon	Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
000C56 (2010)	Pierre-Olivier Fernagut [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Sandra Dovero [France] ; Piu Chan [République populaire de Chine] ; Tao Wu [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Zhenwen Chen [République populaire de Chine] ; Erwan Bezard [France, République populaire de Chine]	Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
000C60 (????)	David Maltête [France] ; Anne Marie Cottard ; Bruno Mihout ; Jean Costentin	Erythrocytes catechol-o-methyl transferase activity is up-regulated after a 3-month treatment by entacapone in parkinsonian patients.
000D11 (2011)	Wassilios G. Meissner [France] ; Mark Frasier ; Thomas Gasser ; Christopher G. Goetz ; Andres Lozano ; Paola Piccini ; José A. Obeso ; Olivier Rascol ; Anthony Schapira ; Valerie Voon ; David M. Weiner ; François Tison ; Erwan Bezard	Priorities in Parkinson's disease research.
000D50 (2011)	Siobhan Vicente [France] ; Julie Péron ; Isabelle Biseul ; Sophie Ory ; Pierre Philippot ; Sophie Drapier ; Dominique Drapier ; Marc Vérin	Subjective emotional experience at different stages of Parkinson's disease.
000E14 (2011)	Sylvia Navailles [France] ; Manolo Carta ; Martin Guthrie ; Philippe De Deurwaerdère	L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
000E97 (2012)	P. De Deurwaerdère [France] ; S. Navailles	What can we expect from the serotonergic side of L-DOPA?
000F16 (2012)	Adrian Degardin [France] ; David Devos ; Luc Defebvre [France] ; Alain Destée [France] ; Lucie Plomhause ; Philippe Derambure ; Hervé Devanne	Effect of intermittent theta-burst stimulation on akinesia and sensorimotor integration in patients with Parkinson's disease.
001015 (2013)	David Devos [France] ; Caroline Moreau ; Arnaud Delval ; Kathy Dujardin ; Luc Defebvre [France] ; Regis Bordet	Methylphenidate : a treatment for Parkinson's disease?
001046 (2013)	Lukasz Szyrwiel [France] ; J Zsef S. Pap ; Wieslaw Malinka ; Zbigniew Szewczuk ; Aleksandra Kotynia ; Justyna Brasun	Interactions of anti-Parkinson drug benserazide with Zn(II), Cu(II), Fe(II) ions.
001049 (2013)	Romina Aron Badin [France] ; Brigitte Spinnewyn [France] ; Marie-Claude Gaillard [France] ; Caroline Jan [France] ; Carole Malgorn [France] ; Nadja Van Camp [France] ; Frédéric Dollé [France] ; Martine Guillermier [France] ; Sabrina Boulet [France] ; Anne Bertrand [France] ; Marc Savasta [France] ; Michel Auguet [France] ; Emmanuel Brouillet [France] ; Pierre-Etienne Chabrier [France] ; Philippe Hantraye [France]	IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
001100 (2013)	Michel Engeln [France] ; Stefania Fasano ; Serge H. Ahmed ; Martine Cador ; Veerle Baekelandt ; Erwan Bezard ; Pierre-Olivier Fernagut	Levodopa gains psychostimulant-like properties after nigral dopaminergic loss.
001112 (2013)	S. Navailles [France] ; M. Lagière [France] ; A. Contini [France] ; P. De Deurwaerdère [France]	Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Induced Dopamine and Serotonin Release in the Parkinsonian Brain

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024